Cart
sales@molnova.com
Clanfenur
CAS No. 51213-99-1
Clanfenur ( —— )
Catalog No. M20195 CAS No. 51213-99-1
Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 91 | In Stock |
|
| 5MG | 131 | In Stock |
|
| 10MG | 186 | In Stock |
|
| 25MG | 336 | In Stock |
|
| 50MG | 480 | In Stock |
|
| 100MG | 687 | In Stock |
|
| 500MG | 1431 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameClanfenur
-
NoteResearch use only not for human use.
-
Brief DescriptionClanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
-
DescriptionClanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number51213-99-1
-
Formula Weight335.76
-
Molecular FormulaC16H15ClFN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:soluble
-
SMILESCN(C)c1cccc(F)c1C(=O)NC(=O)Nc1ccc(Cl)cc1
-
Chemical NameN-((4-chlorophenyl)carbamoyl)-2-(dimethylamino)-6-fluorobenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jonkman-de Vries J D Bj V D B ten Bokkel-Huinink W W et al. Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur[J]. Pda J Pharm Sci Technol 1997 51(2):89-95.
molnova catalog
related products
-
NGI-1
NGI-1 is a a cell-permeable inhibitor of oligosaccharyltransferase (OST).can effectively reduce virus infectivity without affecting cell viability.
-
Methyl ganoderate E
The fruit body of Ganoderma lucidum.
-
Netupitant
Netupitant is a specific neurokinin 1 (NK1) receptor antagonist (Ki: 0.95 nM).
